Activation of hypoxia-inducible factor attenuates renal injury in rat remnant kidney

Nephrology Dialysis Transplantation

Volumn 25, Issue 1, 2010, Pages 77-85

  Song, Young Rim ^a   You, Sun Jin ^b   Lee, Yun Mi ^b   Chin, Ho Joon ^b,c   Chae, Dong Wan ^b,c   Oh, Yun Kyu ^c   Joo, Kwon Wook ^c   Han, Jin Suk ^c   Na, Ki Young ^b,c  

^a Hallym University College of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

DMOG (dimethyloxalylglycine); Fibrosis; Inflammation; Oxidative stress; Podocyte injury

Indexed keywords

ANTIOXIDANT; CATALASE; COLLAGEN TYPE 4; DESMIN; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MALONALDEHYDE; OSTEOPONTIN; PODOPLANIN; PROTEIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CHRONIC KIDNEY DISEASE; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE COURSE; EXPERIMENTAL MODEL; EXPERIMENTAL RAT; EXPERIMENTAL STUDY; FIBROSIS; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; INFLAMMATION; KIDNEY INJURY; MACROPHAGE; MALE; NEPHRECTOMY; NONHUMAN; OXIDATIVE STRESS; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; RENAL PROTECTION;

AMINO ACIDS, DICARBOXYLIC; ANIMALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GLUCOSE TRANSPORTER TYPE 1; HYPOXIA-INDUCIBLE FACTOR 1; KIDNEY; KIDNEY DISEASES; MALE; NEPHRECTOMY; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 72949106456     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp454     Document Type: Article

References (53)

1. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 1998; 339: 1448-1456
2. Fine LG, Bandyopadhay D, Norman JT. Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia. Kidney Int 2000; 75: S22-S26
3. Kang DH, Kanellis J, Hugo C et al. Role of the microvascular en-dothelium in progressive renal disease. J Am Soc Nephrol 2002; 13: 806-816
4. Eckardt KU, Rosenberger C, Jürgensen JS et al. Role of hypoxia in the pathogenesis of renal disease. Blood Purif 2003; 21: 253-257
5. Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 2006; 17: 17-25
6. Wang GL, Jiang BH, Rue EA et al. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995; 92: 5510-5514
7. Ivan M, Kondo K, Yang H et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001; 292: 464-468
8. Jaakkola P, Mole DR, Tian YM et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001; 292: 468-472
9. Epstein AC, Gleadle JM, McNeill LA et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001; 107: 43-54
10. Lisztwan J, Imbert G, Wirbelauer C et al. The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity. Genes Dev 1999; 13: 1822-1833
11. Wenger RH, Stiehl DP, Camenisch G. Integration of oxygen signaling at the consensus HRE. Sci STKE 2005; 2005: re12
12. Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 2004; 5: 343-354
13. Milkiewicz M, Pugh CW, Egginton S. Inhibition of endogenous HIF inactivation induces angiogenesis in ischaemic skeletal muscles of mice. J Physiol 2004; 560: 21-26
14. Ockaili R, Natarajan R, Salloum F et al. HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation. Am J Physiol Heart Circ Physiol 2005; 289: H542-H548
15. Hill P, Shukla D, Tran MG et al. Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury. J Am Soc Nephrol 2008; 19: 39-46
16. Matsumoto M, Makino Y, Tanaka T et al. Induction of renoprotective gene expression by cobalt ameliorates ischemic injury of the kidney in rats. J Am Soc Nephrol 2003; 14: 1825-1832
17. Bernhardt WM, Câmpean V, Kany S et al. Preconditional activation of hypoxia-inducible factors ameliorates ischemic acute renal failure. J Am Soc Nephrol 2006; 17: 1970-1978
18. Weidemann A, Bernhardt WM, Klanke B et al. HIF activation protects from acute kidney injury. J Am Soc Nephrol 2008; 19: 486-494
19. Tanaka T, Matsumoto M, Inagi R et al. Induction of protective genes by cobalt ameliorates tubulointerstitial injury in the progressive Thy1 nephritis. Kidney Int 2005; 68: 2714-2725
20. Tanaka T, Kojima I, Ohse T et al. Cobalt promotes angiogenesis via hypoxia-inducible factor and protects tubulointerstitium in the remnant kidney model. Lab Invest 2005; 85: 1292-1307
21. Higgins DF, Biju MP, Akai Y et al. Hypoxic induction of Ctgf is directly mediated by Hif-1. Am J Physiol Renal Physiol 2004; 287: F1223-F1232
22. Higgins DF, Kimura K, Bernhardt WM et al. Hypoxia promotes fi-brogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 2007; 117: 3810-3820
23. Shimojo H. Adaptation and distortion of podocytes in rat remnant kidney. Pathol Int 1998; 48: 368-383
24. Fogo AB. Animal models of FSGS: lessons for pathogenesis and treatment. Semin Nephrol 2003; 23: 161-171
25. Na KY, Kim GH, Joo KW et al. Chronic furosemide or hydrochloroth-iazide administration increases H+-ATPase B1 subunit abundance in rat kidney. Am J Physiol Renal Physiol 2007; 292: F1701-F1709
26. Joles JA, Kunter U, Janssen U et al. Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats. J Am Soc Nephrol 2000; 11: 669-683 (Pubitemid 30171876)
27. Koop K, Eikmans M, Wehland M et al. Selective loss of podoplanin protein expression accompanies proteinuria and precedes alterations in podocyte morphology in a spontaneous proteinuric rat model. Am J Pathol 2008; 173: 315-326
28. Fries JW, Sandstrom DJ, Meyer TW et al. Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat. Lab Invest 1989; 60: 205-218
29. Meyer TW, Rennke HG. Increased single-nephron protein excretion after renal ablation in nephrotic rats. Am J Physiol 1988; 255: F1243-F1248
30. Nagata M, Schärer K, Kriz W. Glomerular damage after uninephrec-tomy in young rats. I. Hypertrophy and distortion of capillary architecture. Kidney Int 1992; 42: 136-147
31. Kang DH, Hughes J, Mazzali M et al. Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol 2001; 12: 1448-1457 (Pubitemid 32666327)
32. Manotham K, Tanaka T, Matsumoto M et al. Evidence of tubular hypoxia in the early phase in the remnant kidney model. J Am Soc Nephrol 2004; 15: 1277-1288
33. Nagata M, Kriz W. Glomerular damage after uninephrectomy in young rats. II. Mechanical stress on podocytes as a pathway to sclerosis. Kidney Int 1992; 42: 148-160
34. Pabst R, Sterzel RB. Cell renewal of glomerular cell types in normal rats. An autoradiographic analysis. Kidney Int 1983; 24: 626-631
35. Nagata M, Yamaguchi Y, Ito K. Loss of mitotic activity and the expression of vimentin in glomerular epithelial cells of developing human kidneys. Anat Embryol 1993; 187: 275-279
36. Combs HL, Shankland SJ, Setzer SV et al. Expression of the cyclin kinase inhibitor, p27kip1, in developing and mature human kidney. Kidney Int 1998; 53: 892-896
37. Kriz W, Hackenthal E, Nobiling R et al. A role for podocytes to counteract capillary wall distension. Kidney Int 1994; 45: 369-376
38. Foster RR, Hole R, Anderson K et al. Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes. Am J Physiol Renal Physiol 2003; 284: F1263-F1273
39. Eto N, Wada T, Inagi R et al. Podocyte protection by darbepoetin: preservation of the cytoskeleton and nephrin expression. Kidney Int 2007; 72: 455-463
40. TrznadelK, Pawlicki L, Kedziora J et al. Superoxide anion generation, erythrocytes superoxide dismutase activity, and lipid peroxidation during hemoperfusion and hemodialysis in chronic uremic patients. Free Radic Biol Med 1989; 6: 393-397
41. Paul JL, Man NK, Moatti N et al. Membrane phospholipid peroxi-dation in renal insufficiency and chronic hemodialysis. Nephrologie 1991; 12: 4-7
42. Vaziri ND, Oveisi F, Ding Y. Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension. Kidney Int 1998; 53: 1748-1754
43. Miyata T, Kurokawa K, Van Ypersele De Strihou C. Advanced gly-cation and lipoxidation end products: role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism. J Am Soc Nephrol 2000; 11: 1744-1752
44. Vaziri ND, Dicus M, Ho ND et al. Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency. Kidney Int 2003; 63: 179-185
45. Sindhu RK, Ehdaie A, Vaziri ND et al. Effects of chronic renal failure on caveolin-1, guanylate cyclase and AKT protein expression. Biochim Biophys Acta 2004; 1690: 231-237
46. Vaziri ND, Bai Y, Ni Z et al. Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction. J Pharmacol Exp Ther 2007; 323: 85-93
47. Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem 1995; 64: 97-112
48. Van Den Branden C, Ceyssens B, De Craemer D et al. Antioxidant enzyme gene expression in rats with remnant kidney induced chronic renal failure. Exp Nephrol 2000; 8: 91-96
49. Eddy AA, Giachelli CM. Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 1995; 47: 1546-1557
50. Cummins EP, Seeballuck F, Keely SJ et al. The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gas-troenterology 2008; 134: 156-165
51. Eddy AA. Molecular basis of renal fibrosis. Pediatr Nephrol 2000; 15: 290-301
52. Wilson HM, Walbaum D, Rees AJ. Macrophages and the kidney. Curr Opin Nephrol Hypertens 2004; 13: 285-290
53. Günzler V, Muthukrishnan E, Neumayer HH et al. FG-2216 increases hemoglobin concentration in anemic patients with chronic kidney disease. J Am Soc Nephrol 2005; 16: 758A